BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 309507)

  • 1. Fading: a new cytofluorimetric measure quantifying serotonin in the presence of catecholamines at the cellular level in brain.
    Geyer MA; Dawsey WJ; Mandell AJ
    J Pharmacol Exp Ther; 1978 Nov; 207(2):650-67. PubMed ID: 309507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of chlorimipramine and lysergic acid diethylamide on efflux of precursor-formed 3-H-serotonin: correlations with serotonergic impulse flow.
    Gallager DW; Aghajanian GK
    J Pharmacol Exp Ther; 1975 Jun; 193(3):785-95. PubMed ID: 168347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An electron microscopic analysis of large granular synaptic vesicles of the brain in relation to monoamine content.
    Bloom FE; Aghajanian GK
    J Pharmacol Exp Ther; 1968 Feb; 159(2):261-73. PubMed ID: 5638647
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effects of coadministration of fluoxetine and WAY-100635 on serotonergic neurotransmission in vivo: sensitivity to sequence of injections.
    Taber MT; Kinney GG; Pieschl RL; Yocca FD; Gribkoff VK
    Synapse; 2000 Oct; 38(1):17-26. PubMed ID: 10941137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some metabolic and behavioural effects of LSD.
    Kabes J; Fink Z; Somlev A; Vrba J; Mádlo Z
    Act Nerv Super (Praha); 1972 Nov; 14(4):294-5. PubMed ID: 5083833
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 8. Pressor effects of electrical stimulation of the dorsal and median raphe nuclei in anesthetized rats.
    Kuhn DM; Wolf WA; Lovenberg W
    J Pharmacol Exp Ther; 1980 Aug; 214(2):403-9. PubMed ID: 6104727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for serotonin synthesis-dependent regulation of in vitro neuronal firing rates in the midbrain raphe complex.
    Evans AK; Reinders N; Ashford KA; Christie IN; Wakerley JB; Lowry CA
    Eur J Pharmacol; 2008 Aug; 590(1-3):136-49. PubMed ID: 18577382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possible involvement of dopamine in the long-term serotonin depletion by p-chloroamphetamine and beta,beta-difluoro-p-chloroamphetamine in rats.
    Henderson MG; Perry KW; Fuller RW
    J Pharmacol Exp Ther; 1993 Oct; 267(1):417-24. PubMed ID: 8229770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine, fenfluramine and their N-dealkylated metabolites: effect on monoamine concentrations in rat tissues.
    Morgan CD; Cattabeni F; Costa E
    J Pharmacol Exp Ther; 1972 Jan; 180(1):127-35. PubMed ID: 5010410
    [No Abstract]   [Full Text] [Related]  

  • 12. Histofluorescence studies of central monoamines. Comparison of Falck, cryostat and SPG methods.
    Smiałowska M
    Folia Histochem Cytochem (Krakow); 1979; 17(3):215-24. PubMed ID: 488857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional distribution of brain catecholamines and serotonin.
    Dahlström A
    Neurosci Res Program Bull; 1971 Mar; 9(2):197-205. PubMed ID: 5164695
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of drugs on the firing of serotonin-containing neurons in brain.
    Aghajanian GK
    Fed Proc; 1972; 31(1):91-6. PubMed ID: 4333252
    [No Abstract]   [Full Text] [Related]  

  • 15. Sleep in schizophrenia and depression--studies of sleep loss in man and animals.
    Bliss EL
    Res Publ Assoc Res Nerv Ment Dis; 1967; 45():195-210. PubMed ID: 6083190
    [No Abstract]   [Full Text] [Related]  

  • 16. Some effects of the behaviorally active drug, phenitrone, a purported hashish and LSD antagonist, on brain noradrenergic and serotonergic systems.
    Spaulding TC; Dewey WL
    Res Commun Chem Pathol Pharmacol; 1975 Jul; 11(3):503-6. PubMed ID: 1153889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thin-layer chromatographic determination of brain catecholamines and 5-hydroxytryptamine.
    Alemany G; Nicolau MC; Gamundí A; Rial R
    Biomed Chromatogr; 1993; 7(6):315-6. PubMed ID: 8298287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the regulation of tryptophan hydroxylase in brain.
    Zivkovic B; Guidotti A; Costa E
    Adv Biochem Psychopharmacol; 1974; 11(0):19-30. PubMed ID: 4152484
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential effects of monoamine oxidase inhibitors.
    Maickel RP; Rompalo AM; Cox RH
    Res Commun Chem Pathol Pharmacol; 1974 Aug; 8(4):727-30. PubMed ID: 4420181
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the effects of losulazine and reserpine on central aminergic neurons.
    Pan JT; Hooth MJ; Lookingland KJ; Moore KE; Marks TA
    Toxicol Appl Pharmacol; 1993 Nov; 123(1):26-33. PubMed ID: 8236258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.